Ardigen at ASCO18

Topic:

Between June 1st and 5th our representation joined nearly 40 thousand people attending American Society of Clinical Oncology Annual Meeting in Chicago. This year’s ASCO theme was “Delivering Discoveries: Expanding the Reach of Precision Medicine”.

During those five days we attended sessions, talked to speakers and exhibitors, discussed posters and gathered knowledge especially focusing on immuno-oncology. Among the inspiring topics we were able to touch were current clinical advances of various biomarker strategies for companion diagnostics, exciting clinical trials results, and future directions of precision medicine in oncology.

Please have a look at our blog to read more about our impressions from the meeting.

You might be also interested in:

Accelerating biomarker discovery through omic data integration into drug screens
Accelerating biomarker discovery through omic data integration
Two scientists observing AI-driven cell analysis on a digital screen, representing decision-making in biotech innovation.
Build or Buy? Strategic Considerations for Biotech Companies Implementing AI Solutions
biotech US market
AI in biotech: What the US market got right (and what it’s still learning)
From Data Chaos to Drug Discovery – Ardigen Talk at NextGen Omics Conference

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!